ENG/中
老虎证券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登录
立即注册
Toggle
美股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
VIVUS Inc
0.4665
0.0000
成交量:
- -
成交额:
- -
市值:
833.53万
市盈率:
-0.17
高:
0.4665
开:
0.4665
低:
0.4665
收:
0.4665
52周最高:
4.75
52周最低:
0.4369
股本:
1,786.77万
流通股本:
1,482.35万
量比:
- -
换手率:
- -
股息:
- -
股息率:
- -
每股收益(TTM):
-2.7026
每股收益(LYR):
-2.9605
净资产收益率:
47.47%
总资产收益率:
-2.20%
市净率:
-0.11
市盈率(LYR):
-0.16
数据加载中...
总览
公司
新闻资讯
公告
公司资料
公司名字:
VIVUS Inc
交易所:
NASDAQ
成立时间:
- -
员工人数:
- -
公司地址:
- -
官网:
http://www.vivus.com
邮编:
- -
电话:
- -
传真:
- -
简介:
Vivus, Inc.是一家生物制药公司,美国FDA批准两种治疗:Qsymia慢性体重管理和STENDRA勃起功能障碍。 STENDRA也被批准由欧洲委员会,或EC,商品名,SPEDRA,勃起功能障碍在欧盟的治疗。 Qsymia(芬特明和托吡酯缓释)2012年7月被美国FDA批准,作为辅助低热量饮食和增加了慢性体重管理的成人患者体力活动与30或初始体重指数(BMI)更大(肥胖),或27或更大(超重)中的至少一个与体重相关的合并症,如高血压,2型糖尿病或高胆固醇(血脂异常)的存在。 Qsymia采用了专利配方,从两个以前批准的药品,芬特明和托吡酯结合低剂量的活性成分。虽然动作的确切机制是未知的,Qsymia被认为抑制食欲和增加饱腹感,或充满的感觉,这种影响饮食行为的两个主要机制。在2012年9月,通过Qsymia认证送货上门的网络数量有限成为美国市场上。 2013年7月,Qsymia通过约8000沃尔格林,Costco公司成为零售药店提供杜安里德药店nationwide.公司在美国加州于1991年成立并且于1996年重新合并在特拉华州。
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/VVUS/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VVUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVUS\",,,,,undefined,":{"symbol":"VVUS","market":"US","secType":"STK","nameCN":"VIVUS Inc","latestPrice":0.4665,"timestamp":1594929600000,"preClose":0.4665,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":14823450,"shares":17867697,"eps":-2.702649,"marketStatus":"退市","change":0,"latestTime":"02-20 12:10:16 EST","open":0.4665,"high":0.4665,"low":0.4665,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.702649,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1771621200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":765604800000,"exchange":"NASDAQ","adjPreClose":0.4665,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VVUS\",,,,,undefined,":{"symbol":"VVUS","floatShares":14823450,"roa":"-2.20%","roe":"47.47%","lyrEps":-2.96053,"shares":17867697,"dividePrice":0,"high":0.4665,"amplitude":0,"preClose":0.4665,"low":0.4665,"week52Low":0.4369,"pbRate":"-0.11","week52High":4.75,"institutionHeld":0.1227,"latestPrice":0.4665,"eps":-2.702649,"divideRate":0,"volume":0,"delay":0,"ttmEps":-2.702649,"open":0.4665},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VVUS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-06","symbol":"VVUS","fiscalQuarterEnding":"2020/03","expectedEps":-0.8,"name":null,"time":"盘后","type":"earning","dateTimestamp":1588737600000,"reportTimeType":"post","actualEps":-0.49},{"date":"2020-03-03","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/12","expectedEps":-0.59,"defaultRemindTime":1583269200000,"name":null,"time":"盘后","dateTimestamp":1583211600000,"actualEps":null},{"date":"2019-11-05","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-0.62,"defaultRemindTime":1572987600000,"name":null,"time":"盘后","dateTimestamp":1572930000000,"actualEps":null},{"date":"2019-08-06","symbol":"VVUS","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-1,"defaultRemindTime":1565121600000,"name":null,"time":"盘后","dateTimestamp":1565064000000,"actualEps":-1.2},{"market":"US","date":"2019-04-30","symbol":"VVUS","fiscalQuarterEnding":"2019/03","expectedEps":-1.17,"name":null,"time":"盘后","type":"earning","dateTimestamp":1556596800000,"reportTimeType":"post","actualEps":-0.75}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VVUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VVUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VVUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VVUS","date":"2020-07-15","current":-0.172608,"percent":0.938697,"low":-1.245839,"twenty":-0.999217,"median":-0.717023,"eighty":-0.611569,"high":-0.284472,"avg":-0.763673,"sd":0.220207,"marketCap":10838545},"quantilePoints":[],"updateTime":1771598014138},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.vivus.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.1167},{"period":"ytd","weight":0.0038}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Vivus, Inc.是一家生物制药公司,美国FDA批准两种治疗:Qsymia慢性体重管理和STENDRA勃起功能障碍。 STENDRA也被批准由欧洲委员会,或EC,商品名,SPEDRA,勃起功能障碍在欧盟的治疗。 Qsymia(芬特明和托吡酯缓释)2012年7月被美国FDA批准,作为辅助低热量饮食和增加了慢性体重管理的成人患者体力活动与30或初始体重指数(BMI)更大(肥胖),或27或更大(超重)中的至少一个与体重相关的合并症,如高血压,2型糖尿病或高胆固醇(血脂异常)的存在。 Qsymia采用了专利配方,从两个以前批准的药品,芬特明和托吡酯结合低剂量的活性成分。虽然动作的确切机制是未知的,Qsymia被认为抑制食欲和增加饱腹感,或充满的感觉,这种影响饮食行为的两个主要机制。在2012年9月,通过Qsymia认证送货上门的网络数量有限成为美国市场上。 2013年7月,Qsymia通过约8000沃尔格林,Costco公司成为零售药店提供杜安里德药店nationwide.公司在美国加州于1991年成立并且于1996年重新合并在特拉华州。","exchange":"NASDAQ","name":"VIVUS Inc","nameEN":"VIVUS Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"VVUS\",market:\"US\",,,undefined,":null}}